www.oncologytube.com – Page 2 – MashupMD

Mashup Score: 0

Robert M. Rifkin, MD- Analysis of the Connect® Multipl - 2 year(s) ago

Dr. Rifkin is a board-certified medical oncologist and hematologist who treats blood malignancies and diseases, both malignant and benign. He specializes i

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  https://t.co/svZU7aRryy

Mashup Score: 0

Podcast Ping Ye, PhD @TheUSONetwork #ASCO22 #OncoTwitte - 2 year(s) ago

Ping Ye, Ph.D., a senior data scientist for the U.S. Oncology Network, and McKesson. In this audio, she speaks about the ASCO 2022 Abstract – The initial o

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  🧑‍⚕️Dr. Pin Ye from @TheUSONetwork 🗣️ spoke with us about the #ASCO22 abstact Initial Outcome Of Deploying A Mortality Prediction Outcome Of Deploying A Mortality Prediction Tool⚒️. #OncoTwitter @OncoAlert 🔊 https://t.co/5kgNZ9QKFf https://t.co/9xHr0K1eFW

Mashup Score: 2

Ping Ye, PhD @TheUSONetwork #ASCO22 #OncoTwitter @oncoa - 2 year(s) ago

Ping Ye, Ph.D., a senior data scientist for the U.S. Oncology Network, and McKesson. In this video, she speaks about the ASCO 2022 Abstract – The initial o

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  🧑‍⚕️Dr. Pin Ye from @TheUSONetwork 🗣️ spoke with us about the #ASCO22 abstact Initial Outcome Of Deploying A Mortality Prediction Outcome Of Deploying A Mortality Prediction Tool⚒️. #OncoTwitter @OncoAlert 📺https://t.co/AgvXl2WYqS https://t.co/kVebngCMDv

Mashup Score: 0

Debra A. Patt, MD @dapattmd @TexasOncology @TheUSOnetwo - 2 year(s) ago

Debra A. Patt, MD, Ph.D., MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas On

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  👩‍⚕️Dr. @dapattmd from @TexasOncology spoke with us about the #ASCO22 abstract Analyzing 🧑🏻‍🤝‍🧑🏼 Engagement With Digital Health 🧪 Tools ⚒️. @TheUSONetwork #OncoTwitter @OncoAlert 📺 https://t.co/E31oOaxYz9 https://t.co/jVQYWaTuKh

Mashup Score: 3

Podcast Debra A. Patt, MD @dapattmd @TexasOncology @The - 2 year(s) ago

Debra A. Patt, MD, Ph.D., MBA, FASCO, is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas On

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  👩‍⚕️Dr. @dapattmd from @TexasOncology spoke with us about the #ASCO22 abstract Analyzing 🧑🏻‍🤝‍🧑🏼 Engagement With Digital Health 🧪 Tools ⚒️. @TheUSONetwork #OncoTwitter @OncoAlert 🔊 https://t.co/xpJ2i0Td8S https://t.co/BdJWfHjORN

Mashup Score: 1

Douglas W. Blayney, MD @BlayneyDouglas @StanfordMed @Be - 2 year(s) ago

Douglas W. Blayney, MD, FASCO, Clinical researcher and breast oncologist, Professor of Medicine at Stanford University. In this video, he speaks about the

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  🧑‍⚕️Dr. @BlayneyDouglas from @StanfordMed spoke with us about the #ASCO22 abstract Phase 3️⃣ Real-🌍 Effectiveness Of G-CSF In 🧑🏻‍🤝‍🧑🏼 with BC 🎗️. @BeyondSpringInc #OncoTwitter @OncoAlert 📺 https://t.co/7YQIxCybdJ https://t.co/Qr8iAW2hrR

Mashup Score: 1

Podcast Douglas W. Blayney, MD @BlayneyDouglas @Stanfor - 2 year(s) ago

Douglas W. Blayney, MD, FASCO, Clinical researcher and breast oncologist, Professor of Medicine at Stanford University. In this audio, he speaks about the

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  🧑‍⚕️Dr. @BlayneyDouglas from @StanfordMed spoke with us about the #ASCO22 abstract Phase 3️⃣ Real-🌍 Effectiveness Of G-CSF In 🧑🏻‍🤝‍🧑🏼 with BC 🎗️. @BeyondSpringInc #OncoTwitter @OncoAlert 🔊 https://t.co/BXYPdOu4Cz https://t.co/55arSW0Nth

Mashup Score: 0

ASCO 2021 Lung Recap: IMpower010: Atezolizumab after Ch - 2 year(s) ago

Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for 2021. For this series

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  https://t.co/bobJNIlPKe

Mashup Score: 0

Karim Chamie, MD @UclaUrology #ASCO22 #OncoTwitter Phas - 2 year(s) ago

Karim Chamie, MD, Associate Professor of Urology and Society of Urologic Oncology Fellowship Director at UCLA Health. In this video, he speaks about the AS

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  https://t.co/dotbe7CIv0

Mashup Score: 1

Podcast Richard Kim, MD @MoffittNews #ASCO22 #OncoTwitt - 2 year(s) ago

Richard Kim, MD, Professor, clinical and research interests focus on gastrointestinal tumors, in particular, hepatobiliary and colon cancer at Moffitt Canc

Source: www.oncologytube.com

Categories: Hem/Onc News and Journals, Latest Headlines

Tweet Tweets with this article
- oncologytube
  
  👨‍⚕️ Dr. Richard Kim from @MoffittNews spoke with us today about the #ASCO22 abstract - 🗝️🗒️-6️⃣5️⃣1️⃣ Long-Term Follow-Up, Pembro ➕ mFOLFOX7 or FOLFIRI for 👫 with CRC. #OncoTwitter @oncoalert 🔊 https://t.co/bGJTu6CB1V https://t.co/UoFyBURFGw